{
    "ticker": "IBIO",
    "name": "iBio, Inc.",
    "description": "iBio, Inc. is a biotechnology company focused on the development and commercialization of innovative biologic products for the prevention and treatment of human diseases. Founded in 2010 and headquartered in Bryan, Texas, iBio leverages its proprietary technology platform to produce biopharmaceuticals rapidly and cost-effectively. The company's unique approach utilizes plant-based expression systems, which allows for the efficient manufacturing of proteins, antibodies, and vaccines. iBio aims to address critical healthcare challenges, including infectious diseases and cancer, by developing therapies that can be produced at scale in a fraction of the time compared to traditional methods. Additionally, iBio has established partnerships with various organizations to advance its product pipeline, which includes therapeutic candidates in various stages of development. The company\u2019s mission is to enhance the accessibility of biopharmaceuticals globally and to contribute to public health through innovative solutions. As iBio continues to expand its research and development efforts, it remains committed to scientific excellence and the potential of plant-based biomanufacturing to revolutionize the biotech industry.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Bryan, Texas, USA",
    "founded": "2010",
    "website": "https://www.ibioinc.com",
    "ceo": "Thomas Isett",
    "social_media": {
        "twitter": "https://twitter.com/iBioInc",
        "linkedin": "https://www.linkedin.com/company/ibio-inc/"
    },
    "investor_relations": "https://investors.ibioinc.com",
    "key_executives": [
        {
            "name": "Thomas Isett",
            "position": "CEO"
        },
        {
            "name": "Robert Erwin",
            "position": "President"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "IBIO-100",
                "IBIO-200"
            ]
        },
        {
            "category": "Vaccines",
            "products": [
                "Plant-based Vaccines"
            ]
        }
    ],
    "seo": {
        "meta_title": "iBio, Inc. | Innovating Biopharmaceuticals from Plants",
        "meta_description": "Explore iBio, Inc., a leader in plant-based biopharmaceuticals, dedicated to developing innovative therapies and vaccines for human diseases.",
        "keywords": [
            "iBio",
            "Biotechnology",
            "Biopharmaceuticals",
            "Vaccines",
            "Plant-based Therapies",
            "Thomas Isett"
        ]
    },
    "faq": [
        {
            "question": "What does iBio specialize in?",
            "answer": "iBio specializes in the development of plant-based biopharmaceuticals for the treatment of diseases."
        },
        {
            "question": "Who is the CEO of iBio?",
            "answer": "The CEO of iBio is Thomas Isett."
        },
        {
            "question": "Where is iBio headquartered?",
            "answer": "iBio is headquartered in Bryan, Texas, USA."
        },
        {
            "question": "What types of products does iBio develop?",
            "answer": "iBio develops therapeutics, vaccines, and other biologic products using its proprietary technology."
        },
        {
            "question": "When was iBio founded?",
            "answer": "iBio was founded in 2010."
        }
    ],
    "competitors": [
        "REGN",
        "NVAX",
        "VIR"
    ],
    "related_stocks": [
        "GILD",
        "AMGN",
        "MRNA",
        "BMY"
    ]
}